• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Skip to navigation
Close Ad

The Spoon

Daily news and analysis about the food tech revolution

  • Home
  • Podcasts
  • Events
  • Newsletter
  • Connect
    • Custom Events
    • Slack
    • RSS
    • Send us a Tip
  • Advertise
  • Consulting
  • About
The Spoon
  • Home
  • Podcasts
  • Newsletter
  • Events
  • Advertise
  • About

With American’s Growing Focus on Microbiome Health, Will Fiber Gain Starring Role Next to Protein in Diets?

by Michael Wolf
January 24, 2025January 24, 2025Filed under:
  • CES
  • News
  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on Reddit (Opens in new window)
  • Click to email this to a friend (Opens in new window)

At CES last week, The Spoon hosted a panel of experts to discuss the role of personalized nutrition in addressing critical global health challenges, including obesity, diabetes, and chronic diseases.

Moderated by nutrition expert Carolyn O’Neil, the panel featured Noosheen Hashemi of January AI, Ranjan Sinha of Digbi Health, and Matt Barnard of OneBio. Together, they delved into how innovations in artificial intelligence, microbiome science, and biotechnology are transforming how we eat and improve our health.

O’Neil began the session by highlighting the significant impact of diet-related illnesses on public health and the increasing reliance on pharmaceutical interventions, such as GLP-1 drugs like Ozempic. While these medications offer effective solutions for managing conditions like obesity and diabetes, the panelists stressed the importance of addressing root causes, including poor dietary habits, fiber deficiencies, and the lack of personalized guidance.

Ranjan Sinha, founder of Digbi Health, emphasized the critical role that genetics and the gut microbiome play in metabolic health.

“Food has been the cause of many illnesses, but it can also be the cure,” Sinha explained. Digbi Health leverages advanced technology to analyze genetic data, gut microbiome profiles, and telemetry from wearable devices to create customized wellness plans.

Sinha also underscored the untapped potential of microbiome research, describing it as the “next pharmaceutical frontier.” He likened its trajectory to the evolution of electronics, predicting that microbiome-based treatments will dominate healthcare in the coming decades.

“Think about where electronics were in the 1990s, and then the leap to smartphones in the 2000s,” he said. “That’s where microbiome science is headed. In the next 15 to 20 years, your gut could effectively function as a pharmaceutical factory, producing compounds to prevent and treat illness.”

Both Sinha and Matt Barnard highlighted the essential role of fiber in health, directly linking it to the microbiome’s function. By nourishing the microbiome with the fibers it requires, they argued, we could unlock its potential to prevent and even reverse chronic diseases.

Barnard compared the importance of fiber to the early discoveries of vitamins and minerals, signaling a paradigm shift in how fiber is viewed in relation to health.

“One hundred years ago, we didn’t know the importance of vitamins and minerals,” Barnard noted. “Now, deficiencies are rare. The same transformation is happening with fiber. As we learn more, it will revolutionize our approach to chronic disease and metabolic health.”

Noosheen Hashemi, CEO of January AI, agreed with Barnard and Sinha on fiber’s vital role in supporting the human microbiome.

“One of the biggest drivers of inflammation in our collective microbiome is the lack of fiber,” she explained. “Our ancestors, just 12,000 years ago, consumed 100 to 150 grams of fiber daily. Today, our intake is drastically lower. Add to that antibiotics and other factors, and we’re collectively in a state of dysbiosis. It’s essential to ensure people get enough fiber.”

Hashemi also shared insights into January AI’s innovative technology, which predicts a food’s impact on blood sugar using a simple photo of the meal. By analyzing millions of data points, the AI can forecast blood sugar responses to meals, even without requiring wearables like glucose monitors.

The panelists collectively predicted a future where pharmaceutical interventions are complemented by greater reliance on dietary strategies. These strategies will increasingly be informed by technologies capable of analyzing a person’s biomarkers in near real time.

This panel left me wondering if we might see a more significant emphasis on fiber by Americans who, by nearly all accounts, have become overly obsessed with maxing out their protein as a way to feel full and hopefully lose weight. With all the emphasis on gut health and the clear connection to fiber, I think there’s certainly a chance some of it break through for everyday consumers looking for ways to stay health and maintain a healthy weight and microbiome.

That said, it’s likely Americans’ fixation won’t end soon. As Mike Lee said on a (separate) panel recently, “Protein is the Tom Cruise of the American diet.”

In other words, protein’s starring role won’t end anytime soon, but maybe there’s a chance fiber may someday get equal billing.

You can watch the full CES panel on personalized nutrition below

The Future of Personalized Nutrition in the Era of Ozempic


Related

Nutrition Brand Muniq Aims to Support Gut Health and Close Gaps in Health Disparities

Approximately 133 million Americans live with chronic diseases such as heart disease, cancer, and diabetes. On top of this, there is a major issue with health disparities in the U.S. as racial and ethnic minorities are 1.5-2 times more likely to develop a chronic disease compared to Caucasians. Marc Washington,…

The Key to Your Perfect Diet Could Be Hiding in Your DNA

Our DNA contains the code that dictates how our body works — including, apparently, information about which foods we should (and shouldn't) be eating. Dr. Sherry Zhang is on a mission to help individuals eat healthier based on their unique genetic code. That's why she created GenoPalate, the DNA-driven personalized…

COP26 Spotlight: Eagle Genomics and the New Frontier of Microbiome Data

The microbiome is the collective genetic material of all the microorganisms that inhabit an environment, like the human gut or a particular soil. Eagle Genomics, an England-based company, is developing a platform that uses data about that genetic material to drive innovation.At yesterday’s special COP26 session on nutrition and health…

Get the Spoon in your inbox

Just enter your email and we’ll take care of the rest:

Find us on some of these other platforms:

  • Apple Podcasts
  • Spotify
Tagged:
  • CES
  • CES 2025
  • fiber
  • microbiome

Post navigation

Previous Post Video Game Pro? Why Not Join Our Farm: Farmers Seek New Skills to Attract Workers
Next Post Is LG’s Majority Stake in Bear Robotics a Sign That Food Robotics Is About to Have Its Moment?

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Get The Spoon in Your Inbox

The Spoon Podcast Network!

Feed your mind! Subscribe to one of our podcasts!

Food Waste Gadgets Can’t Get VC Love, But Kickstarter Backers Are All In
Report: Restaurant Tech Funding Drops to $1.3B in 2024, But AI & Automation Provide Glimmer of Hope
Don’t Forget to Tip Your Robot: Survey Shows Diners Not Quite Ready for AI to Replace Humans
A Week in Rome: Conclaves, Coffee, and Reflections on the Ethics of AI in Our Food System
How ReShape is Using AI to Accelerate Biotech Research

Footer

  • About
  • Sponsor the Spoon
  • The Spoon Events
  • Spoon Plus

© 2016–2025 The Spoon. All rights reserved.

  • Facebook
  • Instagram
  • LinkedIn
  • RSS
  • Twitter
  • YouTube
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.